In the present study, in order to examine the potential advantages of co-introduction of a chemokine-chemokine receptor axis for antitumor adoptive immunotherapy, we employed as a model genetically redirected T cells targeting WT1 for the treatment of human lung cancer. This evidence concerns the gene WT1 and lung cancer.